Late-onset cerebellar ataxia: A genetic avenue uncovered
Could an anomaly in the developing brain explain motor difficulties occurring decades later in people with rare movement disorders?
Oct 8, 2025
0
11
MeSH tree: C10.228.662.550
Could an anomaly in the developing brain explain motor difficulties occurring decades later in people with rare movement disorders?
Oct 8, 2025
0
11
A new study by the University of Turku and Turku University Hospital, Finland, found that a significant proportion of Parkinson's disease diagnoses are later corrected. Up to one in six diagnoses changed after 10 years of ...
Apr 7, 2025
0
0
University of Florida researchers have led a multicenter study demonstrating that Automated Imaging Differentiation for Parkinsonism (AIDP), a machine-learning method using magnetic resonance imaging (MRI), accurately distinguishes ...
Research led by the University of Michigan has provided compelling evidence that could solve a fundamental mystery in the makeup of fibrils that play a role in Alzheimer's, Parkinson's and other neurodegenerative diseases.
Oct 31, 2024
0
21
In a study published in Neuron, researchers have identified four new genetic risk factors for multiple system atrophy (MSA), shedding light on this poorly understood disorder. The study, which involved collaboration from ...
May 8, 2024
0
2
Although Parkinson's disease has been recognized for more than 100 years, no treatments can slow or halt the disease's progress, let alone cure it. One of the major factors underlying this lack of progress is our relatively ...
Apr 2, 2024
0
41
Dreams are excursions of our central nervous system, unfolding when the body is at rest, but our brains are in thrall to rapid eye movement (REM) sleep. For people with a rare condition, their whole body acts out the dream, ...
Mar 1, 2024
0
0
Multiple system atrophy is a rare and fatal neurodegenerative disease, where insoluble inclusions of the protein alpha-synuclein appear in oligodendrocyte cells of the brain. The resulting pathogenesis features neuroinflammation, ...
Feb 12, 2024
0
35
In the development of Parkinson's disease (PD), the changes that will lead to neurodegeneration take place in the brain long before patients show any symptoms. But without a test that can detect these changes, it's difficult ...
Jan 8, 2024
0
26
Grégoire Courtine, Jocelyne Bloch and their research team have been breaking new ground in the treatment of neurological disorders for over a decade. Here's a look at some of the promising new therapies they've developed.
Jan 8, 2024
0
0